Tuesday, April 23, 2024
wellness India Expo
Home Tags FY24

Tag: FY24

Credit profile of Indian pharma companies to remain healthy in FY2025:...

Revenue growth to moderate to 8-10% in FY2025, post a healthy 13-14% YoY expansion in FY2024